Laboratorios Farmacéuticos Rovi SA (1ROVI)
MTA
Closed
Oct 2, 2026
Day's Range
58.1552 wk Range
55.05Overview - 1ROVI - Laboratorios Farmacéuticos Rovi SA
Key Statistics
Valuation
Enterprise Value
2.95B
P/E (Trailing)
15.92
Price / Sales (TTM)
3.81
Price / Book
4.20
EV / EBITDA
16.77
Profitability
Gross Margin
68.67%
Profit Margin
23.95%
Operating Margin
9.41%
Return on Assets
9.44%
Return on Equity
28.65%
Ownership
Shares Outstanding
51.14M
Float
16.20M
Held by Insiders
68.19%
Held by Institutions
16.76%
Price stats
Beta
0.23
50-Day Avg
58.55
200-Day Avg
66.47
Dividends
Payout Ratio
25.83%
Market Cap - 1ROVI - Laboratorios Farmacéuticos Rovi SA
Peers - 1ROVI - Laboratorios Farmacéuticos Rovi SA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
- 1ROVIMTALaboratorios Farmacéuticos Rovi SA3.32BMarket Cap-11.87%52-week change15.93P/E (Trailing)23.95%Profit Margin
- 1MRKMTAMerck KGaA55.65BMarket Cap+19.49%52-week change24.81P/E (Trailing)11.21%Profit Margin
- 1ZTSMTAZoetis Inc. Class A Common Stock48.46BMarket Cap-99.48%52-week change11.41P/E (Trailing)27.68%Profit Margin
- 1GALDMTAGalderma Group AG41.32BMarket Cap+15.70%52-week change53.11P/E (Trailing)14.57%Profit Margin
- 1NBIXMTANeurocrine Biosciences, Inc.12.55BMarket Cap+2.03%52-week change20.07P/E (Trailing)20.91%Profit Margin
- 1VTRSMTAViatris Inc.12.51BMarket Cap+46.86%52-week change-5.09P/E (Trailing)-2.78%Profit Margin
- 1SOBIMTASwedish Orphan Biovitrum AB10.24BMarket Cap+36.40%52-week change117.09P/E (Trailing)4.51%Profit Margin
Profile Summary - 1ROVI - Laboratorios Farmacéuticos Rovi SA
About
Laboratorios Farmacéuticos Rovi SA is a Spanish biotechnology and pharmaceutical company specializing in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. Founded in 1946, it operates through two primary segments: Manufacturing, focused on contract development and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
